Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
BMJ Open|December 21, 2012
An international measure of awareness and beliefs about cancer: development and testing of the ABCAlice E Simon, Lindsay J L Forbes, David Boniface, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trialH Bonnefoi, S Litière, M Piccart, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trialO Metzger Filho, F Cardoso, C Poncet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 studyH Bonnefoi, W Jacot, M Saghatchian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancerE Vrdoljak, N Marschner, C Zielinski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trialM Ignatiadis, S Litière, F Rothe, et al.
British Journal of Cancer|July 23, 2013
International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancerS Wheelwright, A-S Darlington, D Fitzsimmons, et al.
Breast (Edinburgh, Scotland)|October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trialF Valet, P de Cremoux, F Spyratos, et al.
ESMO Open|May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohortN Epaillard, A Lusque, W Jacot, et al.
ESMO Open|September 4, 2024
Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working GroupK P Loh, G Liposits, S P Arora, et al.
Pageof 11